<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>ir-10054-10544</identifier><datestamp>2011-12-27T05:45:16Z</datestamp><dc:title>Antimalarial activity of 3-hydroxyalkyl-2-methylenepropionic acid derivatives</dc:title><dc:creator>KUNDU, MK</dc:creator><dc:creator>SUNDAR, N</dc:creator><dc:creator>KUMAR, SK</dc:creator><dc:creator>BHAT, SV</dc:creator><dc:creator>BISWAS, S</dc:creator><dc:creator>VALECHA, N</dc:creator><dc:subject>baylis-hillman reaction</dc:subject><dc:description>Several Baylis-Hillman adducts and their derivatives were synthesized and evaluated as targeted potential anti-malarials, The compounds 4, 7 and 9 were found to have highest potency against P. falciparum in vitro. The in vivo test result of compound 4 and 9 against P. berghei demonstrated activity at 80 mg/Kg dose level. (C) 1999 . .</dc:description><dc:publisher>PERGAMON-ELSEVIER SCIENCE LTD</dc:publisher><dc:date>2011-08-23T14:20:10Z</dc:date><dc:date>2011-12-26T12:56:28Z</dc:date><dc:date>2011-12-27T05:45:16Z</dc:date><dc:date>2011-08-23T14:20:10Z</dc:date><dc:date>2011-12-26T12:56:28Z</dc:date><dc:date>2011-12-27T05:45:16Z</dc:date><dc:date>1999</dc:date><dc:type>Article</dc:type><dc:identifier>BIOORGANIC &amp; MEDICINAL CHEMISTRY LETTERS, 9(5), 731-736</dc:identifier><dc:identifier>0960-894X</dc:identifier><dc:identifier>http://dx.doi.org/10.1016/S0960-894X(99)00057-8</dc:identifier><dc:identifier>http://dspace.library.iitb.ac.in/xmlui/handle/10054/10544</dc:identifier><dc:identifier>http://hdl.handle.net/10054/10544</dc:identifier><dc:language>en</dc:language></oai_dc:dc>